Picture of Extendicare logo

EXE — Extendicare News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

Senior care operator Extendicare Q3 revenue beats estimates, helped by home health care growth

Overview

Extendicare Q3 revenue beats analyst expectations

Adjusted EBITDA increased driven by home health care growth

Company completed acquisition of Closing the Gap for C$75.1 mln in cash

Outlook

Company anticipates C$1.1 mln in annualized cost synergies from Closing the Gap acquisition

Company sees opportunity for further acquisitions in fragmented seniors care market

Result Drivers

HOME HEALTH CARE GROWTH - Co attributes Q3 revenue increase to 24.6% growth in home health care ADV, including contributions from Closing the Gap

ACQUISITIONS BOOST - Revenue growth driven by acquisition of Closing the Gap and nine Class C LTC homes

LONG-TERM CARE IMPROVEMENTS - Co cites improved LTC funding and occupancy rates as contributors to revenue growth

Key Details

MetricBeat/MissActualConsensus Estimate
Q3 RevenueBeatC$440.28 mlnC$415.40 mln (2 Analysts)
Q3 Net IncomeC$24.12 mln
Q3 Adjusted EBITDAC$50.77 mln
Q3 Adjusted FFOC$29.54 mln
Q3 Adjusted EBITDA Margin11.50%
Q3 Operating ExpensesC$374.37 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell" The average consensus recommendation for the healthcare facilities & services peer group is "buy" Wall Street's median 12-month price target for Extendicare Inc is C$16.50, about 2.2% above its November 10 closing price of C$16.14 The stock recently traded at 17 times the next 12-month earnings vs. a P/E of 14 three months ago Press Release: ID:nGNX1Xw2rM For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Extendicare

See all news